Yourgene Health (YGEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

10.46p
   
  • Change Today:
      0.26p
  • 52 Week High: 14.80
  • 52 Week Low: 4.00
  • Currency: UK Pounds
  • Shares Issued: 417.64m
  • Volume: 755,564
  • Market Cap: 43.69m
  • Beta: 0.01

YGEN Overview

Yourgene Health is in the pharma and biotech sector and is currently trading at 10.46p per share. In the last year Yourgene Health 's share price has ranged from 4.00p to 14.80p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

YGEN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-14 0.06 (4.93) (0.24)p n/a n/a n/a n/a 0.0%
31-Mar-15 0.13 (7.45) (5.00)p n/a n/a n/a n/a 0.0%
31-Mar-16 2.45 (12.12) (6.00)p n/a n/a n/a n/a 0.0%
31-Mar-17 3.08 (7.85) 3.00p 3.9 n/a n/a n/a 0.0%
31-Mar-18 6.15 (9.54) 3.00p 1.5 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

YGEN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-19 8.50 (5.50) (1.00)p n/a n/a n/a n/a 0.0%
31-Mar-20 11.90 (2.40) (0.40)p n/a n/a n/a n/a 0.0%
31-Mar-21 15.00 (1.20) (0.20)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

YGEN Company Announcements

Yourgene launches Sage 32 plex 08-Jan-2019 07:00 RNS
Half-year Results 03-Dec-2018 07:00 RNS
Change of Name to Yourgene Health plc 07-Nov-2018 07:00 RNS

Latest YGEN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

YGEN Market Data

Currency UK Pounds
Share Price 10.46p
Change Today 0.26p
% Change 2.55 %
52 Week High 14.80
52 Week Low 4.00
Volume 755,564
Shares Issued 417.64m
Market Cap 43.69m
Beta 0.01

YGEN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
94.91% above the market average94.91% above the market average94.91% above the market average94.91% above the market average94.91% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
63.94% above the market average63.94% above the market average63.94% above the market average63.94% above the market average63.94% above the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average

YGEN Dividends

No dividends found

Trades for 16-Jan-2019

Time Volume / Share Price
14:19 6,587 @ 10.46p
14:18 8,278 @ 10.45p
14:07 50,000 @ 10.59p
13:59 18,807 @ 10.59p
12:26 60,000 @ 10.42p

YGEN Key Personnel

CFO Barry Kenneth Hextall
CEO Lyn Rees
COO Keng Hsu

Top of Page